These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 37575679)
1. In-silico identification of small molecule benzofuran-1,2,3-triazole hybrids as potential inhibitors targeting EGFR in lung cancer via ligand-based pharmacophore modeling and molecular docking studies. Kumar S; Ali I; Abbas F; Khan N; Gupta MK; Garg M; Kumar S; Kumar D In Silico Pharmacol; 2023; 11(1):20. PubMed ID: 37575679 [TBL] [Abstract][Full Text] [Related]
2. In-silico identification and exploration of small molecule coumarin-1,2,3-triazole hybrids as potential EGFR inhibitors for targeting lung cancer. Kumar S; Ali I; Abbas F; Shafiq F; Yadav AK; Ghate MD; Kumar D Mol Divers; 2024 Mar; ():. PubMed ID: 38470555 [TBL] [Abstract][Full Text] [Related]
3. Kumar S; Ali I; Abbas F; Rana A; Pandey S; Garg M; Kumar D J Biomol Struct Dyn; 2023 Aug; ():1-23. PubMed ID: 37646177 [TBL] [Abstract][Full Text] [Related]
4. Identification and exploration of quinazoline-1,2,3-triazole inhibitors targeting EGFR in lung cancer. Kumar S; Sengupta S; Ali I; Gupta MK; Lalhlenmawia H; Azizov S; Kumar D J Biomol Struct Dyn; 2023; 41(21):11353-11372. PubMed ID: 37114510 [TBL] [Abstract][Full Text] [Related]
5. An Exploration of the Inhibitory Mechanism of Rationally Screened Benzofuran-1,3,4-Oxadiazoles and-1,2,4-Triazoles as Inhibitors of NS5B RdRp Hepatitis C Virus through Pharmacoinformatic Approaches. Irfan A; Faisal S; Ahmad S; Saif MJ; Zahoor AF; Khan SG; Javid J; Al-Hussain SA; Muhammed MT; Zaki MEA Biomedicines; 2023 Nov; 11(11):. PubMed ID: 38002085 [TBL] [Abstract][Full Text] [Related]
7. Identification of Novel EGFR Inhibitors for the Targeted Therapy of Colorectal Cancer Using Pharmacophore Modelling, Docking, Molecular Dynamic Simulation and Biological Activity Prediction. Krishnan K A; Valavi SG; Joy A Anticancer Agents Med Chem; 2024; 24(4):263-279. PubMed ID: 38173208 [TBL] [Abstract][Full Text] [Related]
8. Investigation of novel ligand targeting bromodomain-containing protein 4 (BRD4) for cancer drug discovery: complete pharmacophore approach. Shanmugam V; Muthukrishnan S J Biomol Struct Dyn; 2023; 41(23):14524-14539. PubMed ID: 36841551 [TBL] [Abstract][Full Text] [Related]
9. Ligand-Based Pharmacophore Modeling, Molecular Docking, and Molecular Dynamic Studies of Dual Tyrosine Kinase Inhibitor of EGFR and VEGFR2. Sangande F; Julianti E; Tjahjono DH Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33096664 [TBL] [Abstract][Full Text] [Related]
12. Exploration of New and Potent Lead Molecules Against CAAX Prenyl Protease I of Leishmania donovani Through Pharmacophore Based Virtual Screening Approach. Prabhu SV; Tiwari K; Suryanarayanan V; Dubey VK; Singh SK Comb Chem High Throughput Screen; 2017; 20(3):255-271. PubMed ID: 28116998 [TBL] [Abstract][Full Text] [Related]
13. Virtual screening of acetylcholinesterase inhibitors through pharmacophore-based 3D-QSAR modeling, ADMET, molecular docking, and MD simulation studies. Kumar H; Datusalia AK; Khatik GL In Silico Pharmacol; 2024; 12(1):13. PubMed ID: 38370859 [TBL] [Abstract][Full Text] [Related]
14. QSAR modeling, pharmacophore-based virtual screening, and ensemble docking insights into predicting potential epigallocatechin gallate (EGCG) analogs against epidermal growth factor receptor. Bommu UD; Konidala KK; Pabbaraju N; Yeguvapalli S J Recept Signal Transduct Res; 2019 Feb; 39(1):18-27. PubMed ID: 31223050 [TBL] [Abstract][Full Text] [Related]
15. Designing and Patil SM; Shashikant B Curr Drug Discov Technol; 2023; 20(6):47-59. PubMed ID: 37291789 [TBL] [Abstract][Full Text] [Related]
16. In Silico Docking of Medicinal Herbs Against P. gingivalis for Chronic Periodontitis Intervention. Saini RS; Vaddamanu SK; Dermawan D; Bavabeedu SS; Khudaverdyan M; Mosaddad SA; Heboyan A Int Dent J; 2024 Aug; ():. PubMed ID: 39127518 [TBL] [Abstract][Full Text] [Related]
17. Pharmacophore based virtual screening for identification of effective inhibitors to combat HPV 16 E6 driven cervical cancer. Mohan A; Krishnamoorthy S; Sabanayagam R; Schwenk G; Feng E; Ji HF; Muthusami S Eur J Pharmacol; 2023 Oct; 957():175961. PubMed ID: 37549730 [TBL] [Abstract][Full Text] [Related]
18. In silico identification of EGFR-T790M inhibitors with novel scaffolds: start with extraction of common features. Xiang M; Lei K; Fan W; Lin Y; He G; Yang M; Chen L; Mo Y Drug Des Devel Ther; 2013; 7():789-839. PubMed ID: 23990708 [TBL] [Abstract][Full Text] [Related]
19. 1,2,3-triazole and chiral Schiff base hybrids as potential anticancer agents: DFT, molecular docking and ADME studies. Belay Y; Muller A; Mokoena FS; Adeyinka AS; Motadi LR; Oyebamiji AK Sci Rep; 2024 Mar; 14(1):6951. PubMed ID: 38521876 [TBL] [Abstract][Full Text] [Related]
20. In silico screening of chalcone derivatives as promising EGFR-TK inhibitors for the clinical treatment of cancer. Mathpal S; Joshi T; Sharma P; Maiti P; Nand M; Pande V; Chandra S 3 Biotech; 2024 Jan; 14(1):18. PubMed ID: 38130684 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]